US Stock MarketDetailed Quotes

FibroBiologics (FBLG)

Watchlist
  • 1.050
  • -0.030-2.78%
Close May 15 16:00 ET
  • 1.050
  • 0.0000.00%
Post 19:24 ET
5.47MMarket Cap-0.15P/E (TTM)

FibroBiologics (FBLG) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
17.27%-4.36M
-37.75%-16.39M
-2.93%-3.16M
-52.42%-3.97M
-104.62%-3.98M
-23.39%-5.28M
-85.92%-11.9M
-91.94%-3.07M
-128.80%-2.61M
-19.82%-1.95M
Net income from continuing operations
-0.68%-5M
-67.06%-18.65M
-4.68%-3.24M
-1,055.60%-5.78M
-618.71%-4.66M
41.30%-4.97M
32.30%-11.16M
68.11%-3.1M
77.19%-500K
141.55%898K
Operating gains losses
-165.06%-54K
104.77%273K
114.63%296K
98.81%-33K
98.19%-73K
-97.33%83K
-178.30%-5.72M
-127.96%-2.02M
---2.78M
-7,163.16%-4.03M
Depreciation and amortization
47.20%237K
45.20%832K
52.94%234K
61.54%231K
47.14%206K
17.52%161K
31.12%573K
17.69%153K
27.68%143K
41.41%140K
Other non cash items
----
----
----
--0
----
----
2,200.00%1.86M
----
----
----
Change In working capital
84.50%-241K
-692.49%-3.31M
-378.85%-1.34M
231.82%58K
-203.46%-479K
-471.12%-1.56M
13.39%559K
-187.74%-279K
-108.73%-44K
752.11%463K
-Change in prepaid assets
204.32%435K
-550.79%-1.23M
-945.31%-1.08M
481.82%960K
-403.07%-691K
41.27%-417K
-2,600.00%-189K
1,522.22%128K
302.44%165K
1,300.00%228K
-Change in payables and accrued expense
90.78%-95K
-235.07%-1.5M
64.06%-124K
-584.11%-732K
14.63%384K
-183.81%-1.03M
36.95%1.11M
-225.45%-345K
-129.48%-107K
1,556.52%335K
-Change in other current assets
---403K
-1,400.00%-30K
--0
--0
---30K
--0
-114.29%-2K
--0
--0
--0
-Change in other current liabilities
-64.81%-178K
-51.93%-550K
-109.68%-130K
-66.67%-170K
-42.00%-142K
-10.20%-108K
-11.04%-362K
-16.98%-62K
-9.68%-102K
-9.89%-100K
Cash from discontinued investing activities
Operating cash flow
17.27%-4.36M
-37.75%-16.39M
-2.93%-3.16M
-52.42%-3.97M
-104.62%-3.98M
-23.39%-5.28M
-85.92%-11.9M
-91.94%-3.07M
-128.80%-2.61M
-19.82%-1.95M
Investing cash flow
Cash flow from continuing investing activities
0
-42.39%-262K
0
45.45%-6K
-222.73%-213K
-437.50%-43K
62.83%-184K
-4,850.00%-99K
97.34%-11K
-175.00%-66K
Net PPE purchase and sale
--0
-42.39%-262K
--0
45.45%-6K
-222.73%-213K
-437.50%-43K
62.83%-184K
-4,850.00%-99K
97.34%-11K
-175.00%-66K
Cash from discontinued investing activities
Investing cash flow
--0
-42.39%-262K
--0
45.45%-6K
-222.73%-213K
-437.50%-43K
62.83%-184K
-4,850.00%-99K
97.34%-11K
-175.00%-66K
Financing cash flow
Cash flow from continuing financing activities
952K
-55.26%7.57M
-65.81%3.19M
0
2,643.60%4.38M
0
22.58%16.91M
9.33M
375.64%4.47M
89.96%-172K
Net issuance payments of debt
--246K
-89.63%975K
-136.62%-3.4M
--0
2,643.60%4.38M
--0
3,033.33%9.4M
--9.29M
---172K
-157.33%-172K
Net common stock issuance
--706K
-12.22%6.59M
14,544.44%6.59M
--0
--0
--0
--7.51M
--45K
--4.64M
--0
Net preferred stock issuance
----
----
----
----
----
----
--0
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
--952K
-55.26%7.57M
-65.81%3.19M
--0
2,643.60%4.38M
--0
22.58%16.91M
--9.33M
375.64%4.47M
89.96%-172K
Net cash flow
Beginning cash position
-65.01%4.89M
52.62%13.99M
-37.82%4.87M
48.08%8.85M
6.24%8.67M
52.62%13.99M
304.37%9.16M
-27.30%7.83M
-47.50%5.97M
-44.65%8.16M
Current changes in cash
35.84%-3.41M
-288.53%-9.09M
-99.56%27K
-314.56%-3.98M
108.15%178K
-429.15%-5.32M
-30.09%4.82M
484.15%6.16M
402.94%1.85M
35.01%-2.19M
End cash Position
-82.90%1.48M
-65.01%4.89M
-65.01%4.89M
-37.82%4.87M
48.08%8.85M
6.24%8.67M
52.62%13.99M
52.62%13.99M
-27.30%7.83M
-47.50%5.97M
Free cash flow
17.94%-4.36M
-37.82%-16.66M
0.28%-3.16M
-52.01%-3.98M
-108.49%-4.2M
-24.17%-5.32M
-75.25%-12.09M
-97.88%-3.17M
-68.62%-2.62M
-22.07%-2.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 17.27%-4.36M-37.75%-16.39M-2.93%-3.16M-52.42%-3.97M-104.62%-3.98M-23.39%-5.28M-85.92%-11.9M-91.94%-3.07M-128.80%-2.61M-19.82%-1.95M
Net income from continuing operations -0.68%-5M-67.06%-18.65M-4.68%-3.24M-1,055.60%-5.78M-618.71%-4.66M41.30%-4.97M32.30%-11.16M68.11%-3.1M77.19%-500K141.55%898K
Operating gains losses -165.06%-54K104.77%273K114.63%296K98.81%-33K98.19%-73K-97.33%83K-178.30%-5.72M-127.96%-2.02M---2.78M-7,163.16%-4.03M
Depreciation and amortization 47.20%237K45.20%832K52.94%234K61.54%231K47.14%206K17.52%161K31.12%573K17.69%153K27.68%143K41.41%140K
Other non cash items --------------0--------2,200.00%1.86M------------
Change In working capital 84.50%-241K-692.49%-3.31M-378.85%-1.34M231.82%58K-203.46%-479K-471.12%-1.56M13.39%559K-187.74%-279K-108.73%-44K752.11%463K
-Change in prepaid assets 204.32%435K-550.79%-1.23M-945.31%-1.08M481.82%960K-403.07%-691K41.27%-417K-2,600.00%-189K1,522.22%128K302.44%165K1,300.00%228K
-Change in payables and accrued expense 90.78%-95K-235.07%-1.5M64.06%-124K-584.11%-732K14.63%384K-183.81%-1.03M36.95%1.11M-225.45%-345K-129.48%-107K1,556.52%335K
-Change in other current assets ---403K-1,400.00%-30K--0--0---30K--0-114.29%-2K--0--0--0
-Change in other current liabilities -64.81%-178K-51.93%-550K-109.68%-130K-66.67%-170K-42.00%-142K-10.20%-108K-11.04%-362K-16.98%-62K-9.68%-102K-9.89%-100K
Cash from discontinued investing activities
Operating cash flow 17.27%-4.36M-37.75%-16.39M-2.93%-3.16M-52.42%-3.97M-104.62%-3.98M-23.39%-5.28M-85.92%-11.9M-91.94%-3.07M-128.80%-2.61M-19.82%-1.95M
Investing cash flow
Cash flow from continuing investing activities 0-42.39%-262K045.45%-6K-222.73%-213K-437.50%-43K62.83%-184K-4,850.00%-99K97.34%-11K-175.00%-66K
Net PPE purchase and sale --0-42.39%-262K--045.45%-6K-222.73%-213K-437.50%-43K62.83%-184K-4,850.00%-99K97.34%-11K-175.00%-66K
Cash from discontinued investing activities
Investing cash flow --0-42.39%-262K--045.45%-6K-222.73%-213K-437.50%-43K62.83%-184K-4,850.00%-99K97.34%-11K-175.00%-66K
Financing cash flow
Cash flow from continuing financing activities 952K-55.26%7.57M-65.81%3.19M02,643.60%4.38M022.58%16.91M9.33M375.64%4.47M89.96%-172K
Net issuance payments of debt --246K-89.63%975K-136.62%-3.4M--02,643.60%4.38M--03,033.33%9.4M--9.29M---172K-157.33%-172K
Net common stock issuance --706K-12.22%6.59M14,544.44%6.59M--0--0--0--7.51M--45K--4.64M--0
Net preferred stock issuance --------------------------0--0--0--0
Cash from discontinued financing activities
Financing cash flow --952K-55.26%7.57M-65.81%3.19M--02,643.60%4.38M--022.58%16.91M--9.33M375.64%4.47M89.96%-172K
Net cash flow
Beginning cash position -65.01%4.89M52.62%13.99M-37.82%4.87M48.08%8.85M6.24%8.67M52.62%13.99M304.37%9.16M-27.30%7.83M-47.50%5.97M-44.65%8.16M
Current changes in cash 35.84%-3.41M-288.53%-9.09M-99.56%27K-314.56%-3.98M108.15%178K-429.15%-5.32M-30.09%4.82M484.15%6.16M402.94%1.85M35.01%-2.19M
End cash Position -82.90%1.48M-65.01%4.89M-65.01%4.89M-37.82%4.87M48.08%8.85M6.24%8.67M52.62%13.99M52.62%13.99M-27.30%7.83M-47.50%5.97M
Free cash flow 17.94%-4.36M-37.82%-16.66M0.28%-3.16M-52.01%-3.98M-108.49%-4.2M-24.17%-5.32M-75.25%-12.09M-97.88%-3.17M-68.62%-2.62M-22.07%-2.01M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More